Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs
- 作者Dr Julia Kirchheiner, Ivar Roots, Mark Goldammer, Bernd Rosenkranz, Jürgen Brockmöller
- 卷第44卷
- 期第12期
- 文件大小197.24KB
- 发表时间2005-12
- DOI10.2165/00003088-200544120-00002
- 页码1209-1225
Clinical Pharmacokinetics of CyclophosphamideLouise B. Grochow,Dr Michael Colvin · Clinical Pharmacokinetics · 1979
Clinical Pharmacokinetics of CyclophosphamideDr Malcolm J. Moore · Clinical Pharmacokinetics · 1991
Methods in Clinical Pharmacology || Pharmacokinetics of cyclophosphamide (Endoxan): The balance of cyclophosphamide metabolites in the mouseRietbrock, Norbert; Woodcock, Barry G.; Neuhaus, Günter · 1980
Analysis of cyclophosphamide and carboxyethylphosphoramide mustard enantiomers in human plasma and application to clinical pharmacokineticsCastro, Francine Attié de; Scatena, Gabriel dos Santos; Cass, Quézia Bezerra; Simões, Belinda Pinto; Lanchote, Vera Lucia · Journal of Chromatography B · 2014
The importance of both <i>CYP2C19</i> and <i>CYP2B6</i> germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.Helsby, N.A.; Yong, M.; van Kan, M.; de Zoysa, J.R.; Burns, K.E. · British Journal of Clinical Pharmacology · 2019